Wei Ji-Qing, Wei Ji-Lu, Li Wei-Chun, Bi Yun-Sheng, Wei Feng-Cai
Department of Pediatrics, Maimonides Medical Center, 4802 Tenth Avenue, Brooklyn, New York 11219, USA.
J Clin Endocrinol Metab. 2006 Sep;91(9):3647-53. doi: 10.1210/jc.2006-0153. Epub 2006 Jul 5.
17alpha-Hydroxylase deficiency is a rare form of congenital adrenal hyperplasia caused by CYP17 gene mutations.
Five Chinese patients with 17alpha-hydroxylase deficiency were genotyped.
The five patients derived from four families living in Shandong Province, China. The diagnosis of 17alpha-hydroxylase deficiency was initially established through HPLC serum adrenal profiles in Qilu Hospital, China, from 1983-1993.
Three CYP17 gene mutations were identified from these patients. Among them, V311fs and Y329fs are two novel frame-shifting mutations. V311fs is an 8-bp nucleotide (TTAAATGG) deletion in exon 5. Y329fs is a deletion-insertion combined mutation (TAC-->AA) at codon 329 in exon 6. Two homozygotes for Y329fs and one compound heterozygote for Y329fs and V311fs were identified from three different families. Two homozygous sisters for the D487_S488_F489 deletion were identified.
The results confirmed the diagnostic value of the HPLC serum adrenal profile for 17alpha-hydroxylase deficiency. The D487_S488_F489 deletion had been identified in two previously genotyped Chinese families. In our present study, a third Chinese family with this mutation was identified, suggesting that this mutation is a prevalent CYP17 mutation in the Chinese population. The identification of Y329fs mutation in addition to three previously identified mutations at codon 329 suggests that codon 329 is an unstable point of the CYP17 gene. The mutations identified from our five patients appear to be random, but the recurrence of the Y329fs mutation may be attributed to a founder effect. Our studies suggest that 17alpha-hydroxylase deficiency may not be rare in the Chinese population.
17α-羟化酶缺乏症是一种由CYP17基因突变引起的罕见先天性肾上腺增生症。
对5例中国17α-羟化酶缺乏症患者进行基因分型。
这5例患者来自中国山东省的4个家庭。1983年至1993年期间,在中国齐鲁医院通过高效液相色谱法检测血清肾上腺激素谱初步确诊为17α-羟化酶缺乏症。
从这些患者中鉴定出3种CYP17基因突变。其中,V311fs和Y329fs是两种新的移码突变。V311fs是外显子5中8个碱基对(TTAAATGG)的缺失。Y329fs是外显子6中第329密码子处的缺失-插入复合突变(TAC→AA)。在3个不同家庭中鉴定出2例Y329fs纯合子和1例Y329fs与V311fs的复合杂合子。鉴定出2例D487_S488_F489缺失的纯合姐妹。
结果证实了高效液相色谱法检测血清肾上腺激素谱对17α-羟化酶缺乏症的诊断价值。在之前两个进行基因分型的中国家庭中已鉴定出D487_S488_F489缺失。在本研究中,鉴定出第三个携带此突变的中国家庭,表明该突变在中国人群中是一种常见的CYP17突变。除了之前在第329密码子处鉴定出的3种突变外,Y329fs突变的鉴定表明第329密码子是CYP17基因的一个不稳定位点。从我们的5例患者中鉴定出的突变似乎是随机的,但Y329fs突变的复发可能归因于奠基者效应。我们的研究表明,17α-羟化酶缺乏症在中国人群中可能并不罕见。